 |
|
Current clinical application of dantrolene sodium
Hong Seuk Yang, Jae Moon Choi, Junyong In, Tae-yun Sung, Yong Beom Kim, Shofina Sultana
Anesth Pain Med. 2023;18(3):220-232. Published online 2023 Jul 26 DOI: https://doi.org/10.17085/apm.22260
|
|
Citations to this article as recorded by
 Dantrolene for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy-Induced Painful Muscle Spasms: A Case Report
Yuri Chaves Martins, Sejal V. Jain, Amol M. Patwardhan
A&A Practice.2025; 19(4): e01956. CrossRef Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape
Nimeet Desai, Dhwani Rana, Mitali Patel, Neha Bajwa, Rajendra Prasad, Lalitkumar K. Vora
Small.2025;[Epub] CrossRef Management of Suspected Malignant Hyperthermia With Dantrolene: Clinical Insights From 2 Case Reports in a Single-Center Experience
Nguyen Trung Kien, Tran Nguyen Nhat, Do Dinh Tung, Tran Quang Hai, Le Thi Nguyet, Pham Quang Minh, Luu Quang Thuy, Cong Quyet Thang, Ngo Van Dinh, Vu The Anh, Nguyen Huu Tu, Nguyen Dang Thu
Clinical Medicine Insights: Case Reports.2025;[Epub] CrossRef Nanomedicines: Emerging Platforms in Smart Chemotherapy Treatment—A Recent Review
Mosab Arafat, Molham Sakkal, Rami Beiram, Salahdein AbuRuz
Pharmaceuticals.2024; 17(3): 315. CrossRef Dantrolene paradoxically exacerbates short-term brain glucose hypometabolism, hippocampal damage and neuroinflammation induced by status epilepticus in the rat lithium-pilocarpine model
Luis García-García, Francisca Gómez-Oliver, Rubén Fernández de la Rosa, Miguel Ángel Pozo
European Journal of Pharmacology.2024; 985: 177073. CrossRef
|